43 research outputs found
Hypersomnolence in fibromyalgia syndrome
OBJECTIVE:
To evaluate hypersomnolence in patients affected by fibromyalgia syndrome.
METHODS:
Thirty consecutive patients affected by fibromyalgia syndrome (FMS) (28 F) completed a sleep questionnaire and underwent the following evaluations: lung function tests; polysomnography; the Epworth sleepiness scale (ESS), which measures sleep complaints and daytime hypersomnolence; and the visual analogical scale (VAS) to detect subjective pain, fatigue, anxiety and depression.
RESULTS:
The FMS patients were divided into two groups based on their ESS score. Patients complaining of daytime hypersomnolence had a higher number of tender points (15 +/- 2 vs. 12 +/- 1, p < 0.01), a higher subjective pain score (72 +/- 15 vs. 52 +/- 13, p < 0.05), and more fatigue (p < 0.05). The diffusing capacity of the lung (Tlco) was more impaired and the occurrence of periodic breathing was higher. FMS patients complaining of daytime somnolence had significantly less efficient sleep than the FMS patients with no daytime somnolence (p < 0.05), i.e. a lower proportion of stage 3 sleep (5 +/- 2% vs. 12 +/- 3%; p < 0.001), stage 4 sleep (1 +/- 0.5% vs. 4 +/- 1%; p < 0.001), and twice as many arousals per hour of sleep (p < 0.01). The respiratory pattern of FMS patients with hypersomnolence showed a higher occurrence of periodic breathing (p < 0.05). The short length of apneas and hypopnoeas did not affect the apnea/hypopnea index (5.1 +/- 3 vs. 7 +/- 4; ns), but FMS patients with daytime hypersomnolence had a greater number of desaturations per hour of sleep (11 +/- 6 vs. 6 +/- 5; p < 0.05). Pulmonary volumes did not differ between the two groups. The EES score was significantly correlated in FMS patients, and even more markedly in the FMS patients with hypersomnolence, TLco, A/I, and disease duration. The ESS score was correlated significantly with the number of tender points only in FMS patients with daytime hypersomnolence.
CONCLUSION:
The occurrence of daytime hypersomnolence in FMS patients is linked to a greater severity of fibromyalgia symptoms and to more severe polysomnographic alteration
Autonomic nervous system function assessed by conventional and spectral analysis might be useful in terms of predicting retinal deterioration in persons with type 1 diabetes mellitus
Nocturnal blood pressure fall as predictor of diabetic nephropathy in hypertensive patients with type 2 diabetes
<p>Abstract</p> <p>Background</p> <p>Hypertensive patients with reduced blood pressure fall (BPF) at night are at higher risk of cardiovascular events (CVE).</p> <p>Methods</p> <p>We evaluated in hypertensive diabetic patients, if a reduced nocturnal BPF can precedes the development of diabetic nephropathy (DN). We followed 70 patients with normal urinary albumin excretion (UAE) for two years. We performed 24-hours ambulatory BP monitoring in baseline and at the end of the study.</p> <p>Results</p> <p>Fourteen (20%) patients (GI) developed DN (N = 11) and/or CVE (n = 4). Compared to the remaining 56 patients (GII) in baseline, GI had similar diurnal systolic (SBP) and diastolic BP (DBP), but higher nocturnal SBP (138 ± 15 vs 129 ± 16 mmHg; p < 0.05) and DBP (83 ± 12 vs 75 ± 11 mmHg; p < 0,05). Basal nocturnal SBP correlated with occurrence of DN and CVE (R = 0.26; P < 0.05) and with UAE at the end of the study (r = 0.3; p < 0.05). Basal BPF (%) correlated with final UAE (r = -0.31; p < 0.05). In patients who developed DN, reductions occurred in nocturnal systolic BPF (12 ± 5 vs 3 ± 6%, p < 0,01) and diastolic BPF (15 ± 8 vs 4 ± 10%, p < 0,01) while no changes were observed in diurnal SBP (153 ± 17 vs 156 ± 16 mmHg, NS) and DBP (91 ± 9 vs 90 ± 7 mmHg, NS). Patients with final UAE < 20 μg/min, had no changes in nocturnal and diurnal BP.</p> <p>Conclusions</p> <p>Our results suggests that elevations in nocturnal BP precedes DN and increases the risk to develop CVE in hypertensive patients with T2DM.</p
A 14-year prospective study of autonomic nerve function in Type 1 diabetic patients: association with nephropathy
Diabetic retinopathy is associated with early autonomic dysfunction assessed by exercise-related heart rate changes
Effects of acute and chronic sleep deprivation on cardiovascular regulation
Sleep is a fundamental physiological process, characterized by the activation of several cortical and subcortical neural networks. The relation between sleep and cardiovascular system is complex and bidirectional: sleep disorders may alter cardiovascular system, leading to an increased cardiovascular risk, while, on the contrary, cardiovascular diseases are characterized by an alteration of physiological sleep. Autonomic nervous system (ANS) plays a key role in the regulation of cardiovascular functions during different sleep stages, with sympatho-vagal balance dynamically shifting towards sympathetic or vagal predominance across different sleep stages.
Sleep deprivation (SD) has becoming one of the most relevant health problem in modern societies. SD can be related to aging, which is associated with increased sleep fragmentation, and to sleep disorders, such as sleep disordered breathing and neurological disorders.
Experimental studies in animals showed that SD significantly affects cardiovascular functions, altering heart rate and blood pressure responses, and increasing sympathetic activity and neuroendocrine response to stressor stimuli. Clinical studies in humans have shown that SD, either due to experimental sleep loss and to sleep disorders, can affect different biological pathways, such as cardiovascular autonomic control, inflammation, immunity responses and metabolism. All these alterations may predispose subjects with SD to an increased cardiovascular risk. Hence, it is fundamental to identify the presence of a sleep disorder, which could be per se responsible for sleep loss, or the presence of sleep deprivation due to other factors, such as social life, habits etc., in order to identify subjects at high risk for cardiovascular events
More common microbiological agents responsible of acute exacerbation of COPD in a northern area of Italy
Right-to-left shunt and obstructive sleep apnea in cluster headache
Introduction: Cluster headache (CH) is a trigeminal autonomic cephalalgia characterized by extremely painful, strictly unilateral, headache attacks accompanied by ipsilateral autonomic symptoms. Only few studies investigated a possible role of right-to-left shunt (R-to-LS) and sleep apnea (OSA) in cluster pathogenesis or expression and no prior studies were located that combined the two conditions in CH patients. Objective: To define the potential combined effect of right-to-left shunt and obstructive sleep apnea in patients with cluster headache and their possible influence on the frequency of attacks and on response to oxygen therapy of headache attacks. Methods: 33 patients with cluster headache were recruited and subsequently invited to undergo polysomnography and a transcranial doppler bubble study. Polysomnography is used for the diagnosis of obstructive sleep apnea whereas transcranial doppler bubble study can help diagnose a cardiac right-to-left shunt. Results: Transcranial doppler results demonstrated that 10 out of 31 patients in our cohort had a right-to-left shunt (RLS). Polysomnography revealed that 10 out of 32 patients had obstructive sleep apnea (OSAS). Nineteen out of 33 subjects had one of the two conditions but only one of our 33 patients had both conditions simultaneously. In this sample patients with clear seasonality to their cluster attacks had a higher frequency of obstructive sleep apnea than patients without seasonality. Also a good response to oxygen treatment of the attacks was higher in OSAS patients. Conclusion: the presence of RLS or OSAS, by their possible influence on blood oxygenation, seems to be independently able to predispose to cluster headache or to make it clinically manifest, while the hypothesizable synergistic role between them in favoring cluster headache was not put in evidence. Additionally, our study suggested that the seasonality of cluster headache, may be influenced by the seasonal nature of obstructive sleep apnea. Finally, the presence of sleep breathing alterations seems to be also able to modulate the efficacy of oxygen inhalation on cluster headache attacks